brochure
At Frontage, we simplify the effort of Investigational New Drug (IND) and reduce the risk by offering all of the critical IND-enabling services required to bring your lead candidate to Phase 1. By providing the right comprehensive end-to-end services, we can accelerate your IND program with the benefit of consistent quality, enhanced efficiency, and optimal cross-functional communications.
Register to gain access to gated resources.
"*" indicates required fields